Neurosurgeon Dr. Shafique Virani becomes director of new biopharmaceutical company

Alan Condon -   Print  |

Shafique Virani, MD, on Jan. 10 was appointed director of newly established biopharmaceutical company TauC3 Biologics.

Three things to know:

1. TauC3 Biologics, based in London, is developing an immunotherapy to prevent or halt the spread of neurodegenerative diseases such as Alzheimer's.

2. Dr. Virani completed his neurosurgery residency at the University of Cambridge Teaching Hospitals in England and is currently based in the San Francisco Bay area.

3. He has 15 years of experience in the life sciences industry focusing on building portfolios of companies in neuroscience, rare diseases and precision oncology.

More articles on devices:
Dr. Bryan Little appointed to state medical board, task force
Former Medtronic, Bioventus executive becomes CEO at BlueWind Medical
Exactech co-founders retire, current CEO to transition to board role — 4 insights

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers